RXO (NYSE:RXO) Receives Equal Weight Rating from Stephens

RXO (NYSE:RXOGet Free Report)‘s stock had its “equal weight” rating restated by equities researchers at Stephens in a research note issued on Monday, Benzinga reports. They presently have a $22.00 target price on the stock. Stephens’ target price would indicate a potential upside of 7.16% from the company’s previous close.

A number of other equities analysts have also recently weighed in on the company. Bank of America cut RXO from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $25.00 to $22.00 in a report on Thursday, February 8th. Stifel Nicolaus boosted their price target on RXO from $20.00 to $22.00 and gave the stock a “hold” rating in a research note on Wednesday, January 10th. Oppenheimer reduced their price target on RXO from $23.00 to $22.00 and set an “outperform” rating for the company in a research report on Tuesday, February 13th. Benchmark reaffirmed a “hold” rating on shares of RXO in a research note on Friday, April 19th. Finally, TD Cowen increased their price target on RXO from $19.00 to $20.00 and gave the stock a “hold” rating in a report on Friday. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $20.55.

Read Our Latest Stock Analysis on RXO

RXO Price Performance

Shares of NYSE:RXO traded up $0.12 during trading on Monday, reaching $20.53. The stock had a trading volume of 110,459 shares, compared to its average volume of 653,311. The business’s 50-day moving average price is $20.58 and its 200 day moving average price is $20.91. The stock has a market capitalization of $2.41 billion, a PE ratio of -230.44, a P/E/G ratio of 7.91 and a beta of 1.24. RXO has a 52 week low of $16.94 and a 52 week high of $24.33. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.14 and a quick ratio of 1.17.

RXO (NYSE:RXOGet Free Report) last issued its quarterly earnings data on Thursday, May 2nd. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.01. The firm had revenue of $913.00 million during the quarter, compared to the consensus estimate of $929.50 million. RXO had a negative net margin of 0.29% and a positive return on equity of 3.23%. The business’s revenue for the quarter was down 9.6% compared to the same quarter last year. During the same period last year, the business posted $0.11 earnings per share. As a group, equities analysts predict that RXO will post 0.2 earnings per share for the current year.

Insider Buying and Selling at RXO

In other RXO news, major shareholder Mfn Partners, Lp acquired 5,139 shares of the stock in a transaction on Friday, April 12th. The shares were bought at an average price of $20.39 per share, with a total value of $104,784.21. Following the acquisition, the insider now owns 15,593,694 shares of the company’s stock, valued at $317,955,420.66. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders have acquired a total of 1,942,293 shares of company stock worth $39,332,736 over the last ninety days. Corporate insiders own 1.80% of the company’s stock.

Hedge Funds Weigh In On RXO

A number of institutional investors have recently added to or reduced their stakes in the company. Douglas Lane & Associates LLC lifted its position in shares of RXO by 10.7% in the fourth quarter. Douglas Lane & Associates LLC now owns 2,579,390 shares of the company’s stock worth $59,997,000 after purchasing an additional 248,883 shares in the last quarter. Nisa Investment Advisors LLC increased its position in RXO by 65.6% in the third quarter. Nisa Investment Advisors LLC now owns 6,863 shares of the company’s stock worth $135,000 after purchasing an additional 2,718 shares during the period. Barclays PLC lifted its holdings in shares of RXO by 299.9% during the 3rd quarter. Barclays PLC now owns 270,766 shares of the company’s stock valued at $5,343,000 after purchasing an additional 203,052 shares in the last quarter. GSA Capital Partners LLP raised its stake in shares of RXO by 325.2% during the 3rd quarter. GSA Capital Partners LLP now owns 55,077 shares of the company’s stock worth $1,087,000 after purchasing an additional 42,123 shares in the last quarter. Finally, Motley Fool Asset Management LLC lifted its position in shares of RXO by 151.5% in the third quarter. Motley Fool Asset Management LLC now owns 403,658 shares of the company’s stock valued at $7,964,000 after buying an additional 243,137 shares during the last quarter. Institutional investors and hedge funds own 92.73% of the company’s stock.

RXO Company Profile

(Get Free Report)

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Recommended Stories

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.